Greenwood Luba insider trades
Greenwood Luba has filed 11 Form 4s with the SEC that we hold, for In8Bio, INC. (INAB) (Director), Ernexa Therapeutics Inc. (BTX) (Director) and Traws Pharma, Inc. (TRAW) (Director). Across all of them we count 1 purchase worth $999 and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 526 shares of In8Bio, INC. worth $999, dated 2022-08-16. The first filing on our record is dated 2021-08-02 and the latest 2026-05-12.
In8Bio, INC. (INAB)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-08-16 | P, purchase reported on Form 4 | 526 | $999 | 2022-08-18 |
Ernexa Therapeutics Inc. (BTX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Traws Pharma, Inc. (TRAW)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1853815) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms